Guangdong Hybribio Biotech Co.,Ltd.

SZSE:300639.SZ

8.67 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Assets:
Current Assets:
Cash & Cash Equivalents 764.9321,024.776521.973390.958257.33362.797185.7651.41347.25107.653102.15823.607
Short Term Investments 307.055387.057677.1448605-26.191-16.259000012
Cash and Short Term Investments 1,071.9871,411.8321,199.1161,250.958262.33362.797185.7651.41347.25107.653102.15823.607
Net Receivables 1,988.9212,761.0161,140.696593.58348.817276.534213.082159.337127.188106.44374.41154.244
Inventory 99.558118.739147.14396.30543.41440.20332.50634.76629.26623.60214.87514.682
Other Current Assets 16.46108.69165.51221.28310.067329.771265.9033.3931.965-7.353-5.38412
Total Current Assets 3,176.9254,400.2782,552.4671,962.126664.63709.306697.251248.909205.669230.345186.06104.533
Non-Current Assets:
Property, Plant & Equipment, Net 1,437.3581,316.9591,167.564598.453413.401346.781278.996269.862231.052100.12841.60920.779
Goodwill 000000000000
Intangible Assets 276.801218.767124.712118.764104.58331.30431.27131.1635.04730.89834.27537.667
Goodwill and Intangible Assets 276.801218.767124.712118.764104.58331.30431.27131.1635.04730.89834.27537.667
Long Term Investments 533.125134.92-403.338-784.02210.42136.94123.74212.346.7615.7132.0781.357
Tax Assets 195.346170.20129.20421.06630.61321.40120.12814.53810.3415.3694.6012.882
Other Non-Current Assets 106.236490.001760.776940.57773.3242.52618.2532.3444.95513.2122.42.029
Total Non-Current Assets 2,548.8662,330.8481,678.918894.838632.338478.953372.391330.243288.157155.31984.96264.714
Total Assets 5,725.7916,731.1264,231.3852,856.9641,296.9681,188.2591,069.642579.152493.826385.664271.023169.247
Liabilities & Equity:
Current Liabilities:
Account Payables 143.666466.69221.14786.235.92225.76217.32216.39631.54911.14411.08212.175
Short Term Debt 10.982108.96158.2975.2728.75916.49123.452100.3540.49229.7130.321
Tax Payables 78.098371.219104.47923.01414.58314.47710.2914.8534.9634.9814.7023.77
Deferred Revenue 8.93422.156296.33139.6564.183.311.13131.12825.623.92822.66214.709
Other Current Liabilities 344.334765.0261.8191.89457.35650.8742.6133.0992.8244.0884.4689.432
Total Current Liabilities 507.9161,362.832677.586303.022106.21796.43284.51860.62460.32739.65167.92536.638
Non-Current Liabilities:
Long Term Debt 28.26830.53526.86211.6880.2320.140000.311100.277
Deferred Revenue Non-Current 11.8214.13216.56518.9135.33110.70412.99915.21917.6190.6351.0451.36
Deferred Tax Liabilities Non-Current 61.60296.74335.3590.5840.5480.8931.2251.6432.1690.4650.5590.685
Other Non-Current Liabilities 5.6300-11.5210000000.110
Total Non-Current Liabilities 107.319141.4178.78619.6646.11111.73814.22416.86219.7881.41111.7152.323
Total Liabilities 615.2351,504.242756.373322.686112.328108.1798.74277.48780.11541.06279.6438.961
Equity:
Preferred Stock 000036.80249.80800001.3830
Common Stock 649.15439.516293.894235.382217.381182.00891.01767.567.567.562.1559
Retained Earnings 3,159.7973,200.5181,581.388808.061495.76394.168343.484261.069185.484121.11259.33731.514
Accumulated Other Comprehensive Income/Loss 316.665271.79675.00811.032-36.802-49.8080.011160.92159.0230-1.3830
Other Total Stockholders Equity 735.664994.7371,244.0941,336.059368.577391.273526.088-00155.9969.89639.772
Total Shareholders Equity 4,861.2774,906.5673,194.3852,390.5341,081.718967.449960.6489.489412.007344.602191.383130.286
Total Equity 5,098.7365,226.8843,475.0132,534.2781,184.641,080.088970.9501.665413.711344.602191.383130.286
Total Liabilities & Shareholders Equity 5,725.7916,731.1264,231.3852,856.9641,296.9681,188.2591,069.642579.152493.826385.664271.023169.247